CAMP4 Therapeutics Corporation (“CAMP4”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate gene ...

Bilibili Inc. ('Bilibili” or the 'Company”) (Nasdaq: BILI and HKEX: 9626), an iconic brand and a leading video community for ...

- 4Q 2025 net income available to common shareholders of $100.2 million, or $2.79 Earnings per Share ("EPS"). Full year 2025 net income available to common shareholders of $406.9 million, or $11.40 ...

Gentle yet powerful, peptide serums boost collagen, hydrate deeply, and deliver visible firmness. We tested the top picks ...

Forward contract cover locked in for 99% of 2026 and 81% of 2027. Earnings, cashflow, forward visibility, and return of capital to shareholders materially increased y-o-y maximizing strategic ...

With the CBSE Class 12 Mathematics exam scheduled for March 9, 2026, students across the country are revising formulas and ...

(NASDAQ: GEVO) (“Gevo”, the “Company”, “we”, “us” or “our”), a leader in renewable fuels and chemicals as well as carbon management, today announced financial results for the fourth quarter and full ...

Dermatologists and editors agree – these peptide serums give your skin a youthful glow.

ENDEAVOUR REPORTS STRONG FY-2025 RESULTS Record 2025 free cash flow of $1,156m l Record 2025 shareholder returns of $435m l >$1bn ...